Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Bartonella Infections

para>Advise lab if Bartonella infection is suspected so that cultures are prepared using appropriate media and laboratory conditions; prolonged incubation is required (up to 6 weeks).
  • Polymerase chain reaction (PCR; highly sensitive) of valve tissue can aid in diagnosis of endocarditis; otherwise, less helpful; not widely available (3)

  • Antibiotics may result in false-negative culture.

  • Lab and other workup not required for typical CSD in nontoxic immunocompetent patients

  •  
    Diagnostic Procedures/Other
    Biopsy of lymph nodes for histology and culture if needed; consider biopsy of involved organs.  
    Test Interpretation
    • CSD: granulomas, stellate necrosis, mixed inflammatory infiltrates; bacilli in tissue may be visible using silver impregnation stains (Warthin-Starry).
    • Verruga peruana: neovascular proliferation; bacteria is not usually identified.
    • Endocarditis: Warthin-Starry-stained bacilli may be seen in vegetations.
    • Bacillary angiomatosis
      • Lobular proliferations of small blood vessels with cuboidal endothelial cells interspersed with inflammatory cells, mostly neutrophils.
      • Warthin-Starry stain or electron microscopy may show clusters of bacilli.
    • Bacillary peliosis: blood-filled cystic structures; Warthin-Starry stain may show surrounding clumps of bacilli.

    TREATMENT


    Many cases of CSD are self-limited. Base antibiotic treatment on clinical presentation and disease severity.  

    MEDICATION


    • Antipyretics and analgesics for symptom management
    • Antibiotic choice depends on clinical situation often based on case studies and expert opinion (2)[A].
    • Typical CSD: no clear benefit, azithromycin may speed resolution of extensive lymphadenopathy: adults and children >45.5 kg: 500 mg on day 1,250 mg daily on days 2 to 5; children <45.5 kg: 10 mg/kg on day 1, 5 mg/kg daily on days 2 to 5 (2)[A]
    • Bacteremia: gentamicin 3 mg/kg IV daily for 2 weeks and doxycycline 200 mg PO daily for 4 weeks (2)[B]
    • Oroya fever: chloramphenicol 500 mg (pediatric dose 50 mg/kg/day) PO/IV QID+/- β-lactam (IV: PCN G 3 million U q4h [40,000 units/kg q4h for pediatrics]/PO: PCN V 500 mg QID or 20 mg/kg QID for pediatrics) for 14 days or ciprofloxacin 500 mg BID for 10 days (2)[B]
    • Verruga peruana: rifampin 600 mg PO daily (10 mg/kg/day in children [not to exceed 600 mg/day]) for 2 to 3 weeks (2)[B]
    • Neuroretinitis: doxycycline 100 mg PO BID (in children <8 years old, consider erythromycin 20 mg/kg/day to maximum daily dose of 2 g/day) + rifampin 300 mg PO BID for 4 to 6 weeks (2)[B]. Usually self-limited, so some authors suggest no antibiotics are needed.
    • Trench fever or chronic B. quintana bacteremia without endocarditis: gentamicin 3 mg/kg IV daily for 2 weeks and doxycycline 200 mg PO daily for 4 weeks (2)[A]
    • Bacillary angiomatosis/peliosis: erythromycin 500 mg (pediatric dose 40 mg/kg/day to maximum daily dose of 2 g/day) PO QID or doxycycline 100 mg PO BID for 3 months (4 months for peliosis) (2,3)[B]
    • Endocarditis: gentamicin 1 mg/kg IV TID for 2 weeks + doxycycline 100 mg IV/PO BID for 6 weeks (2,3)[B]

    ALERT

    All HIV-infected patients should receive antibiotic treatment (3)[A].

     

    ISSUES FOR REFERRAL


    Cardiothoracic surgery if endocarditis  

    SURGERY/OTHER PROCEDURES


    • Drain lymph nodes with needle aspiration (usually not necessary).
    • Valve replacement if indicated in endocarditis

    INPATIENT CONSIDERATIONS


    Admission Criteria/Initial Stabilization
    • Consider admission for patients who are immunocompromised, hemodynamically unstable, or may not have access to appropriate antibiotics.
    • High degree of clinical suspicion and awareness of infection risk

    Discharge Criteria
    When hemodynamically stable on oral antibiotics or receiving IV antibiotics through a peripherally inserted central catheter line and fevers have resolved.  

    ONGOING CARE


    FOLLOW-UP RECOMMENDATIONS


    Patient Monitoring
    Immunocompromised patients have increased risk for relapse. Extended periods of antibiotics are recommended.  

    DIET


    No diet modifications needed  

    PATIENT EDUCATION


    • Educate patients about proper vector control.
    • Immunocompromised patients:
      • Consider risk/benefit of cat ownership (3)[A].
      • Only adopt cats >1 year old that are healthy and free of fleas (3)[B].
      • No need to declaw cat, but avoid rough play (3)[A].
      • Immediately wash cat-induced wounds (3)[B].
      • Regular use of cat flea control (3)[B].
      • No benefit in testing cats for Bartonella (3)[B]

    PROGNOSIS


    • CSD: spontaneous resolution usually in 2 to 4 months without specific therapy
    • Other syndromes: with proper treatment, full resolution; if relapse, consider long-term suppressive antibiotics.
    • Oroya fever: if untreated, 40-85% mortality

    COMPLICATIONS


    Disseminated disease can present with specific organ-related findings such as focal seizures or renal microabscesses.  

    REFERENCES


    11 Kaiser  PO, Riess  T, O'Rourke  F, et al. Bartonella spp.: throwing light on uncommon human infections. Int J Med Microbiol.  2011;301(1):7-15.22 Angelakis  E, Raoult  D. Pathogenicity and treatment of Bartonella infections. Int J Antimicrob Agents.  2014;44(1):16-25.33 Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed August 14, 2015; J1-J5.44 Vermeulen  MJ, Verbakel  H, Notermans  DW, et al. Evaluation of sensitivity, specificity and cross-reactivity in Bartonella henselae serology. J Med Microbiol.  2010;59(Pt 6):743-745.

    ADDITIONAL READING


    Prutsky  G, Domecq  JP, Mori  L, et al. Treatment outcomes of human bartonellosis: a systematic review and meta-analysis. Int J Infect Dis.  2013;17(10):e811-e819.  

    CODES


    ICD10


    • A44.9 Bartonellosis, unspecified
    • A28.1 Cat-scratch disease
    • A79.0 Trench fever
    • A44.1 Cutaneous and mucocutaneous bartonellosis
    • A44.8 Other forms of bartonellosis
    • A44.0 Systemic bartonellosis

    ICD9


    • 088.0 Bartonellosis
    • 078.3 Cat-scratch disease
    • 083.1 Trench fever

    SNOMED


    • Bartonellosis (disorder)
    • Cat scratch disease (disorder)
    • Trench fever
    • Oroya fever

    CLINICAL PEARLS


    • Diagnosing Bartonella infections requires a high degree of clinical suspicion.
    • CSD is self-limited in most immunocompetent patients.
    • Immunocompromised patients are at increased risk for occult infections.
    • CSD can be prevented by avoiding stray cats and ensuring proper flea and tick control in domestic pets.
    Copyright © 2016 - 2017
    Doctor123.org | Disclaimer